Skip header and navigation

Refine By

5 records – page 1 of 1.

C-reactive protein is a determinant of first-ever stroke: prospective nested case-referent study.

https://arctichealth.org/en/permalink/ahliterature151353
Source
Cerebrovasc Dis. 2009;27(6):544-51
Publication Type
Article
Date
2009
Author
Jonas Andersson
Lars Johansson
Per Ladenvall
Per-Gunnar Wiklund
Birgitta Stegmayr
Christina Jern
Kurt Boman
Author Affiliation
Department of Medicine and Geriatrics, Skellefteå County Hospital, Skellefteå, Sweden. jonas.so.andersson@vll.se
Source
Cerebrovasc Dis. 2009;27(6):544-51
Date
2009
Language
English
Publication Type
Article
Keywords
C-Reactive Protein - genetics - metabolism
Case-Control Studies
Cerebral Hemorrhage - blood - epidemiology - ethnology
Female
Humans
Male
Middle Aged
Multivariate Analysis
Polymorphism, Genetic - genetics
Predictive value of tests
Prospective Studies
Risk factors
Stroke - blood - epidemiology - ethnology
Sweden
Abstract
C-reactive protein (CRP) is a determinant of stroke, but there are no prospective studies on CRP and first ischemic stroke divided into etiologic subtypes. Our primary aim was to study CRP as a determinant of ischemic stroke, classified according to Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria, and intracerebral hemorrhage (ICH) in a prospective study. A secondary aim was to study the relationship between the 1444C>T polymorphism, plasma levels of CRP and stroke.
The study was a prospective population-based case-referent study nested within the Northern Sweden Cohorts. We defined 308 cases of ischemic stroke and 61 ICH. Two controls for each case were defined from the same cohort.
The OR for the highest (>3 mg/l) versus lowest group (T polymorphism and any stroke subtype.
PubMed ID
19390179 View in PubMed
Less detail

Diabetes mellitus, high BMI and low education level predict sudden cardiac death within 24 hours of incident myocardial infarction.

https://arctichealth.org/en/permalink/ahliterature287962
Source
Eur J Prev Cardiol. 2016 11;23(17):1814-1820
Publication Type
Article
Date
11-2016
Author
Jonas Andersson
Patrik Wennberg
Dan Lundblad
Stefan A Escher
Jan-Håkan Jansson
Source
Eur J Prev Cardiol. 2016 11;23(17):1814-1820
Date
11-2016
Language
English
Publication Type
Article
Keywords
Body mass index
Case-Control Studies
Death, Sudden, Cardiac - epidemiology - etiology
Diabetes Mellitus - epidemiology
Female
Follow-Up Studies
Humans
Incidence
Male
Middle Aged
Myocardial Infarction - epidemiology - etiology
Odds Ratio
Patient Education as Topic
Prognosis
Prospective Studies
Risk Assessment - methods
Risk factors
Risk Management
Sex Factors
Survival Rate - trends
Sweden - epidemiology
Time Factors
Abstract
More than half of cardiovascular mortality occurs outside the hospital, mainly due to consistently low survival rates from out-of-hospital cardiac arrest.
This is a prospective, nested, case-control study derived from the Västerbotten Intervention Programme and the World Health Organization's Multinational Monitoring of Trends and Determinants in Cardiovascular Disease study in northern Sweden (1986-2006). To determine predictors for sudden cardiac death risk factors for cardiovascular disease were compared between incident myocardial infarction with sudden cardiac death (n?=?363) and survivors of incident myocardial infarction (n?=?1998) using multivariate logistic regression analysis.
Diabetes had the strongest association with sudden cardiac death out of all evaluated risk factors (odds ratio (OR) 1.83, 95% confidence interval (CI) 1.30-2.59), followed by low education (OR 1.55, 95% CI 1.19-2.01), high body mass index (OR 1.05, 95% CI 1.02-1.08) and male sex (OR 1.42, 95% CI 1.001-2.01).
The pattern of risk factors for incident myocardial infarction is different among survivors and those who die within 24 hours. The risk factors that contribute the most to death within 24 hours are diabetes mellitus, high body mass index and low education level, and can be addressed at both the public health level and by general practitioners.
PubMed ID
27435083 View in PubMed
Less detail

Dietary inflammatory index and risk of first myocardial infarction; a prospective population-based study.

https://arctichealth.org/en/permalink/ahliterature286526
Source
Nutr J. 2017 Apr 04;16(1):21
Publication Type
Article
Date
Apr-04-2017
Author
Stina Bodén
Maria Wennberg
Bethany Van Guelpen
Ingegerd Johansson
Bernt Lindahl
Jonas Andersson
Nitin Shivappa
James R Hebert
Lena Maria Nilsson
Source
Nutr J. 2017 Apr 04;16(1):21
Date
Apr-04-2017
Language
English
Publication Type
Article
Keywords
Biomarkers - blood
Body mass index
C-Reactive Protein - metabolism
Case-Control Studies
Diet
Exercise
Female
Follow-Up Studies
Humans
Inflammation - blood - epidemiology
Interleukin-6 - blood
Logistic Models
Male
Middle Aged
Myocardial Infarction - blood - epidemiology
Nutrition Assessment
Prospective Studies
Risk factors
Surveys and Questionnaires
Sweden - epidemiology
Abstract
Chronic, low-grade inflammation is an established risk factor for cardiovascular disease. The inflammatory impact of diet can be reflected by concentrations of inflammatory markers in the bloodstream and the inflammatory potential of diet can be estimated by the dietary inflammatory index (DII(TM)), which has been associated with cardiovascular disease risk in some previous studies. We aimed to examine the association between the DII and the risk of first myocardial infarction (MI) in a population-based study with long follow-up.
We conducted a prospective case-control study of 1389 verified cases of first MI and 5555 matched controls nested within the population-based cohorts of the Northern Sweden Health and Disease Study (NSHDS), of which the largest is the ongoing Västerbotten Intervention Programme (VIP) with nearly 100 000 participants during the study period. Median follow-up from recruitment to MI diagnosis was 6.4 years (6.2 for men and 7.2 for women). DII scores were derived from a validated food frequency questionnaire (FFQ) administered in 1986-2006. Multivariable conditional logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI), using quartile 1 (most anti-inflammatory diet) as the reference category. For validation, general linear models were used to estimate the association between the DII scores and two inflammatory markers, high-sensitivity C-reactive protein (hsCRP) and interleukin 6 (IL-6) in a subset (n?=?605) of the study population.
Male participants with the most pro-inflammatory DII scores had an increased risk of MI [ORQ4vsQ1?=?1.57 (95% CI 1.21-2.02) P trend?=?0.02], which was essentially unchanged after adjustment for potential confounders, including cardiovascular risk factors [ORQ4vsQ1?=?1.50 (95% CI 1.14-1.99), P trend?=?0.10]. No association was found between DII and MI in women. An increase of one DII score unit was associated with 9% higher hsCRP (95% CI 0.03-0.14) and 6% higher IL-6 (95% CI 0.02-0.11) in 605 controls with biomarker data available.
A pro-inflammatory diet was associated with an elevated risk of first myocardial infarction in men; whereas for women the relationship was null. Consideration of the inflammatory impact of diet could improve prevention of cardiovascular disease.
Notes
Cites: Int J Epidemiol. 1995 Apr;24(2):389-987635601
Cites: Scand J Prim Health Care. 1998 Sep;16(3):171-69800231
Cites: Ann Epidemiol. 2015 Jun;25(6):398-40525900255
Cites: Prev Med. 2012 May;54 Suppl:S29-3722178471
Cites: Scand J Public Health Suppl. 2003;61:18-2414660243
Cites: Public Health Nutr. 2014 Aug;17 (8):1825-3324107546
Cites: Eur J Clin Nutr. 2011 Jul;65(7):800-721468094
Cites: Eur J Prev Cardiol. 2016 Jan;23 (2):194-20525416041
Cites: Nutr J. 2012 Jun 11;11:4022686621
Cites: J Intern Med. 2011 Oct;270(4):365-7621443679
Cites: Adv Nutr. 2015 Nov 13;6(6):738-4726567198
Cites: J Clin Chem Clin Biochem. 1984 Dec;22(12):895-9046396369
Cites: Public Health Nutr. 2002 Jun;5(3):487-9612003662
Cites: Glob Health Action. 2010 Mar 22;3:null20339479
Cites: Scand J Public Health Suppl. 2003;61:9-1714660242
Cites: Lancet. 2009 Sep 5;374(9692):767-919733769
Cites: Br J Nutr. 2011 Dec;106 Suppl 3:S5-7822133051
Cites: J Nutr. 2015 Mar;145(3):532-4025733469
Cites: Public Health Nutr. 2014 Aug;17 (8):1689-9623941862
Cites: Epidemiology. 1992 Sep;3(5):452-61391139
Cites: Am J Clin Nutr. 2006 Jun;83(6):1369-7916762949
Cites: PLoS Med. 2008 Apr 8;5(4):e7818399716
Cites: Obes Rev. 2010 Feb;11(2):137-4919656309
Cites: Eur J Nutr. 2017 Mar;56(2):683-69226644215
Cites: Br J Nutr. 2012 Oct 28;108(8):1428-3422221517
Cites: Nutrients. 2015 May 29;7(6):4124-3826035241
Cites: Nutr J. 2014 Nov 22;13:10725416917
Cites: Ann Epidemiol. 2002 Nov;12 (8):577-8612495831
Cites: Circulation. 2003 Jan 28;107(3):499-51112551878
Cites: Ann Epidemiol. 2001 Aug;11(6):417-2711454501
Cites: Nutr Res. 2014 Dec;34(12):1058-6525190219
Cites: PLoS One. 2015 Sep 04;10 (9):e013522126340022
Cites: Nutr Res. 2016 May;36(5):391-40127101757
Cites: Circulation. 1994 Jul;90(1):583-6128026046
Cites: J Nutr. 2007 Apr;137(4):992-817374666
Cites: Nature. 2002 Dec 19-26;420(6917):868-7412490960
Cites: Public Health Nutr. 2009 Sep;12(9):1477-8419144238
Cites: Am J Cardiol. 2003 Dec 1;92(11):1335-914636916
Cites: Atherosclerosis. 2016 Oct;253:164-17027498398
Cites: Cent Eur J Immunol. 2015;40(3):380-626648785
Cites: Eur J Clin Nutr. 2010 Aug;64(8):905-1320502473
Cites: Am J Epidemiol. 1997 Dec 15;146(12):1046-559420529
Cites: Am J Clin Nutr. 2016 Mar;103(3):878-8526864363
Cites: Eur J Cardiovasc Prev Rehabil. 2006 Dec;13(6):924-3017143124
Cites: Am J Cardiol. 2003 Jul 3;92(1A):10i-8i12867250
Cites: Public Health Nutr. 2001 Aug;4(4):919-2711527517
Cites: Br J Nutr. 2015 Dec 28;114(12):2074-8226450630
Cites: Atherosclerosis. 2015 Jan;238(1):38-4425437888
Cites: BMJ Open. 2015 Dec 18;5(12):e00965126685034
PubMed ID
28376792 View in PubMed
Less detail

[Mortality after myocardial infarction has decreased in nearly all Swedish counties during the 1990's. Greatest improvement seen in those counties with the worst initial results]

https://arctichealth.org/en/permalink/ahliterature53478
Source
Lakartidningen. 2003 Sep 11;100(37):2838-44
Publication Type
Article
Date
Sep-11-2003
Author
Max Köster
Jonas Andersson
Kenneth Carling
Måns Rosén
Author Affiliation
Epidemiologiskt centrums stöd åt de nationella kvalitetsregistren, Epidemiologiskt centrum, Socialstyrelsen, Stockholm. max.koster@sos.se
Source
Lakartidningen. 2003 Sep 11;100(37):2838-44
Date
Sep-11-2003
Language
Swedish
Publication Type
Article
Keywords
Comorbidity
Comparative Study
English Abstract
Female
Humans
Male
Myocardial Infarction - mortality
Registries
Sweden - epidemiology
Abstract
In an international perspective, Sweden has a very low case fatality after acute myocardial infarction (AMI). The aim of this study was to present trends and regional differences in case fatality within 28 days of the first AMI for males and females in Sweden after adjusting for co-morbidity. Adjustments in order to remove random effects on the rank order of county councils were made. The study was based on national data on more than 500,000 cases of AMI. Between 1987 and 1999, case fatality after AMI decreased from 47% to 37% among men and from 44% to 34% among women. The case fatality in the individual counties varied from 29% to 37% for men and from 31% to 40% for women. Further analysis is needed in order to explain these variations.
PubMed ID
14558167 View in PubMed
Less detail

Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation.

https://arctichealth.org/en/permalink/ahliterature292204
Source
J Hypertens. 2018 01; 36(1):151-158
Publication Type
Journal Article
Research Support, Non-U.S. Gov't
Date
01-2018
Author
Sebastian Völz
Jonas Spaak
Johan Elf
Christina Jägrén
Christer Lundin
Anna Stenborg
Jonas Andersson
Bengt Rundqvist
Thomas Kahan
Bert Andersson
Author Affiliation
Department of Cardiology, Sahlgrenska Academy at Gothenburg University, Gothenburg.
Source
J Hypertens. 2018 01; 36(1):151-158
Date
01-2018
Language
English
Publication Type
Journal Article
Research Support, Non-U.S. Gov't
Keywords
Abdomen
Aged
Antihypertensive Agents - therapeutic use
Blood pressure
Blood Pressure Monitoring, Ambulatory
Female
Humans
Hypertension - drug therapy - surgery
Kidney
Male
Middle Aged
Registries
Renal Artery - innervation
Sweden
Sympathectomy - methods - statistics & numerical data
Time Factors
Treatment Outcome
Abstract
Renal denervation (RDN) is a catheter-based intervention to treat patients with resistant hypertension. The biological effects of RDN are not fully understood, and randomized controlled trials have generated conflicting evidence. This report presents data from the Swedish Registry for Renal Denervation, an investigator-driven nationwide registry.
To assess the safety and efficacy of RDN on patients with resistant hypertension in a real-world clinical setting.
This nationwide database contains patient characteristics, procedural details, and follow-up data on all RDN procedures performed in Sweden. Consecutive procedures between 2011 and 2015 were included.
The data analysis consists of 252 patients (mean age 61?±?10 years, 38% women; mean 4.5?±?1.5 antihypertensive drugs). Office SBP and DBP and 24-h ambulatory blood pressure (BP) decreased 6 months after RDN (176?±?23/97?±?17 to 161?±?26/91?±?16?mmHg, both P?
Notes
CommentIn: J Hypertens. 2018 Jan;36(1):41-42 PMID 29210859
PubMed ID
29210862 View in PubMed
Less detail